Clinical trial
Evaluation of COVID-19 by Whole-body FDG-PET/CT
NCT05009563 is registered in ClinicalTrials.gov with Semmelweis University Heart and Vascular Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of COVID-19 by Whole-body FDG-PET/CT
- Lead sponsor
- Semmelweis University Heart and Vascular Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 4, 2021
- Completion date
- January 4, 2022
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus infection